BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chagas AL, Mattos AA, Carrilho FJ, Bittencourt PL, Vezozzo DCP, Horvat N, Rocha MS, Alves VAF, Coral GP, Alvares-DA-Silva MR, Barros FMDR, Menezes MR, Monsignore LM, Coelho FF, Silva RFD, Silva RCMA, Boin IFSF, D Albuquerque LAC, Garcia JHP, Felga GEG, Moreira AM, Braghiroli MIFM, Hoff PMG, Mello VB, Dottori MF, Branco TP, Schiavon LL, Costa TFA; Members of the Panel of the 2nd Consensus of the Brazilian Society of Hepatology on the Diagnosis and Management of Hepatocellular Carcinoma. BRAZILIAN SOCIETY OF HEPATOLOGY UPDATED RECOMMENDATIONS FOR DIAGNOSIS AND TREATMENT OF HEPATOCELLULAR CARCINOMA. Arq Gastroenterol 2020;57:1-20. [PMID: 32294682 DOI: 10.1590/S0004-2803.202000000-20] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Filipović A, Mašulović D, Živanović M, Filipović T, Bulatović D, Zakošek M, Nikolić D, Galun D. Impact of the COVID-19 Pandemic on the Outcomes of Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: A Single Center Experience from a Developing Country. Medicina 2022;58:1701. [DOI: 10.3390/medicina58121701] [Reference Citation Analysis]
2 Ferreira da Silva AC, Cunha-silva M, Sevá-pereira T, Mazo DF. Evaluation of the Hepatocellular Carcinoma Predictive Scores PAGE-B and mPAGE-B among Brazilian Patients with Chronic Hepatitis B Virus Infection. Viruses 2022;14:1968. [DOI: 10.3390/v14091968] [Reference Citation Analysis]
3 Silva JPM, Coelho FF, Cassenote AJF, Jeismann VB, Fonseca GM, Kruger JAP, de Meira Júnior JD, Nahas SC, Herman P. Preoperative inflammatory markers as prognostic predictors after hepatocellular carcinoma resection: data from a western referral center. BMC Surg 2022;22:329. [PMID: 36056350 DOI: 10.1186/s12893-022-01779-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bittencourt PL. THE EVOLVING FIELD OF HEPATOLOGY IN BRAZIL. Arq Gastroenterol 2022;59:325-326. [DOI: 10.1590/s0004-2803.202203000-59] [Reference Citation Analysis]
5 Parks LS, Little P. Cirrhosis, Hepatocellular Carcinoma, and Locoregional Therapies. Journal of Radiology Nursing 2022;41:129-135. [DOI: 10.1016/j.jradnu.2022.01.005] [Reference Citation Analysis]
6 Terres AZ, Balbinot RS, Muscope ALF, Longen ML, Schena B, Cini BT, Luis Rost G, Balensiefer JIL, Eberhardt LZ, Balbinot RA, Balbinot SS, Soldera J. Evidence-based protocol for diagnosis and treatment of hepatorenal syndrome is independently associated with lower mortality. Gastroenterología y Hepatología (English Edition) 2022;45:25-39. [DOI: 10.1016/j.gastre.2021.02.009] [Reference Citation Analysis]
7 Tong VJW, Shelat VG, Chao YK. Clinical application of advances and innovation in radiation treatment of hepatocellular carcinoma. J Clin Transl Res 2021;7:811-33. [PMID: 34988334] [Reference Citation Analysis]
8 Ballotin VR, Bigarella LG, Soldera J, Soldera J. Deep learning applied to the imaging diagnosis of hepatocellular carcinoma. Artif Intell Gastrointest Endosc 2021; 2(4): 127-135 [DOI: 10.37126/aige.v2.i4.127] [Reference Citation Analysis]
9 Chen H, Tao M, Li D, Han J, Cheng C, Ma Y, Wu Y, Shelat VG, Tustumi F, Satapathy SK, Kang KJ, Wang Q. An evaluation of the reporting quality in clinical practice guidelines for hepatocellular carcinoma using the RIGHT checklist. Ann Transl Med 2021;9:1004. [PMID: 34277804 DOI: 10.21037/atm-21-2611] [Reference Citation Analysis]
10 Terres AZ, Balbinot RS, Muscope ALF, Eberhardt LZ, Balensiefer JIL, Cini BT, Rost GL, Longen ML, Schena B, Balbinot RA, Balbinot SS, Soldera J. Predicting mortality for cirrhotic patients with acute oesophageal variceal haemorrhage using liver‐specific scores. GastroHep 2021;3:236-46. [DOI: 10.1002/ygh2.460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Terres AZ, Balbinot RS, Muscope ALF, Longen ML, Schena B, Cini BT, Luis Rost G Jr, Balensiefer JIL, Eberhardt LZ, Balbinot RA, Balbinot SS, Soldera J. Evidence-based protocol for diagnosis and treatment of hepatorenal syndrome is independently associated with lower mortality. Gastroenterol Hepatol 2021:S0210-5705(21)00086-8. [PMID: 33746028 DOI: 10.1016/j.gastrohep.2021.02.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Chagas AL, Mattos AA, Diniz MA, Felga GEG, Boin IFSF, Silva RCMA, Silva RF, Garcia JHP, Lima AS, Coelho JCU, Bittencourt PL, Alves VAF, D'Albuquerque LAC, Carrilho FJ; Brazilian HCC Study Group. Impact of Brazilian expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a multicenter study. Ann Hepatol 2021;22:100294. [PMID: 33276136 DOI: 10.1016/j.aohep.2020.100294] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Zulian Terres A, Sartori Balbinot R, Laura Facco Muscope A, Luisa Longen M, Schena B, Teston Cini B, Luis Rost G, Isabel Leichtweis Balensiefer J, Zanotto Eberhardt L, Angelo Balbinot R, Sartori Balbinot S, Soldera J. Predicting mortality for hepatorenal syndrome with liver‐specific scores. GastroHep 2020;2:336-43. [DOI: 10.1002/ygh2.429] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Chagas AL, Fonseca LGD, Coelho FF, Saud LRDC, Abdala E, Andraus W, Fiore L, Moreira AM, Menezes MR, Carnevale FC, Tani CM, Alencar RSSM, D'Albuquerque LAC, Herman P, Carrilho FJ. Management of Hepatocellular Carcinoma during the COVID-19 Pandemic - São Paulo Clínicas Liver Cancer Group Multidisciplinary Consensus Statement. Clinics (Sao Paulo) 2020;75:e2192. [PMID: 33146360 DOI: 10.6061/clinics/2020/e2192] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]